Skip to content
Home/Companies/Healthcare/Mathieu Pharma
Mathieu Pharma

Mathieu Pharma

Healthcare·France·Active·1yr hold
Entry
2025
Hold
1yr
Status
Active

Who owns Mathieu Pharma?

Mathieu Pharma is currently owned by Momentum Invest through Momentum FPCI II (2022 vintage), since 2025.

Hand-verified · updated 2026-04-21

Momentum Invest
Investor
Momentum Invest
Momentum FPCI II · 2022 · Buyout

Key facts

HQFrance
SectorHealthcare
Websitewww.pharmacieveau.fr

More from Momentum FPCI II

Other portfolio companies in the same fund.

Mister IA
Mister IA
Active
AI/MLFrance· 2026
QYYP
Active
TMTFrance· 2025
Agriland
Agriland
Active
AgricultureFrance· 2024
Creacard
Active
FinancialsFrance· 2022
INFOCERT
Infocert
Active
CybersecurityFrance· 2022
Splashr
Exited 2025
TMTFrance· 2022
to

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Mathieu Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Mathieu Pharma?

5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Mathieu Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue